Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INAVOLISIB for Breast cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 36 adverse event reports in the FDA FAERS database where INAVOLISIB was used for Breast cancer.

Most Reported Side Effects for INAVOLISIB

Side Effect Reports % Deaths Hosp.
Hyperglycaemia 54 28.7% 2 19
Blood glucose increased 28 14.9% 0 9
Diarrhoea 21 11.2% 1 10
Stomatitis 20 10.6% 1 3
Fatigue 18 9.6% 0 3
Thrombocytopenia 16 8.5% 0 1
Off label use 14 7.5% 2 6
Diabetic ketoacidosis 13 6.9% 2 7
Nausea 13 6.9% 0 3
Neutropenia 10 5.3% 0 0
Anaemia 7 3.7% 0 1
White blood cell count decreased 7 3.7% 0 1
Acute kidney injury 6 3.2% 0 5
Asthenia 6 3.2% 0 1
Death 6 3.2% 4 1

Other Indications for INAVOLISIB

Breast cancer metastatic (70) Product used for unknown indication (30) Breast cancer female (6) Hormone receptor positive breast cancer (6)

Other Drugs Used for Breast cancer

TRASTUZUMAB (15,522) PALBOCICLIB (13,075) DOCETAXEL (11,735) PACLITAXEL (10,215) LETROZOLE (9,332) CYCLOPHOSPHAMIDE (8,826) PERTUZUMAB (7,532) RIBOCICLIB (6,953) CAPECITABINE (5,767) EPIRUBICIN (5,444)

Related Pages

INAVOLISIB Full Profile All Breast cancer Drugs INAVOLISIB Demographics INAVOLISIB Timeline